Torrent Pharmaceuticals

TORNTPHARM · NSE · INR

4 767,30 ₹Variation par rapport à la clôture précédente: −0,68 %Variation absolue: −32,70 ₹

Clôture · 1 octobre 2026

Profil de la société

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - Specialty & Generic
Pays
Inde
Siège
Avirat, Thaltej Shilaj Road, 380059, Ahmedabad
Salariés
18 258
Cotation
TORNTPHARM · NSE
Devise
INR
ISIN
INE685A01028